[Modern trends in the therapy of congenital and acquired coagulopathies].
D000347:Afibrinogenemia / Q000628:therapy; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000151:congenital / Q000209:etiology / Q000628:therapy*; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D005166:Factor V Deficiency / Q000628:therapy; D005173:Factor XI Deficiency / Q000628:therapy; D005174:Factor XII; D005176:Factor XIII; D006467:Hemophilia A / Q000628:therapy; D002836:Hemophilia B / Q000628:therapy; D006474:Hemorrhagic Disorders / Q000628:therapy; D006490:Hemostatics / Q000009:adverse effects; D006801:Humans; D007020:Hypoprothrombinemias / Q000628:therapy; D012614:Scurvy / Q000628:therapy; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000628:therapy; D014842:von Willebrand Diseases / Q000628:therapy
D001779:Blood Coagulation Factors; D006490:Hemostatics; D005174:Factor XII; D005176:Factor XIII
Moderni orientamenti nella terapia delle coagulopatie congenite ed acquisite.